• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在Cobas Mira上对滥用药物筛查的直接读数免疫测定法进行评估。

Evaluation of DRI enzyme immunoassays for drugs-of-abuse screening on the Cobas Mira.

作者信息

Broussard L A, Hanson L

机构信息

Department of Medical Technology, Louisiana State University Medical Center, New Orleans 70112, USA.

出版信息

Clin Lab Sci. 1997 Mar-Apr;10(2):83-6.

PMID:10166356
Abstract

OBJECTIVE

To establish optimal performance parameters (ratios of sample and reagents, reaction time, and distinction of absorbance values between calibrators) on the Roche Cobas Mira analyzer for the evaluation of Diagnostic Reagents Inc enzyme immunoassay reagents for urine screening of amphetamines, cannabinoids, cocaine metabolite, opiates, and phencyclidine.

SETTING

Laboratory in a physician's office.

PRACTICE DESCRIPTION

Two laboratorians analyze a daily average of 25 urine samples for employment screening purposes. PRODUCT COMPARISON: DRI reagents were compared to Syva EMIT reagents.

RESULTS

Within-run and between-run precision at the cutoff concentration for DRI reagents ranged from 1.1% to 1.6% CV and 2.2% to 5.7% CV respectively. Results (positive or negative) using DRI or Syva EMIT reagents were identical for cannabinoids, cocaine metabolite, opiates and PCP. Direct comparison for amphetamines was not possible because of different cutoff concentrations of the 2 reagents systems.

CONCLUSION

DRI reagents are acceptable alternatives to EMIT reagents for the analysis of amphetamines, cannabinoids, cocaine metabolite, opiates and phencyclidine in urine on the Cobas Mira analyzer. Utilization of DRI reagents for more than 12 months demonstrated the reliability of the reagents and allowed cost comparison.

ABBREVIATIONS

DRI = Diagnostic Reagents Inc; EMIT = enzyme multiplied immunoassay technique; d.a.u. = drugs of abuse; PCP = phencyclidine; GC/MS = gas chromatography/mass spectrometry.

摘要

目的

在罗氏Cobas Mira分析仪上确定最佳性能参数(样本与试剂比例、反应时间以及校准品吸光度值的差异),以评估诊断试剂公司用于尿液中苯丙胺、大麻素、可卡因代谢物、阿片类药物和苯环利定筛查的酶免疫分析试剂。

设置

医生办公室实验室。

实践描述

两名实验室技术人员为就业筛查目的每天平均分析25份尿液样本。

产品比较

将诊断试剂公司的试剂与Syva EMIT试剂进行比较。

结果

诊断试剂公司试剂在临界浓度下的批内精密度和批间精密度的变异系数分别为1.1%至1.6%和2.2%至5.7%。使用诊断试剂公司或Syva EMIT试剂检测大麻素、可卡因代谢物、阿片类药物和苯环利定的结果(阳性或阴性)相同。由于两种试剂系统的临界浓度不同,无法对苯丙胺进行直接比较。

结论

在Cobas Mira分析仪上,诊断试剂公司的试剂是用于尿液中苯丙胺、大麻素、可卡因代谢物、阿片类药物和苯环利定分析的EMIT试剂的可接受替代品。使用诊断试剂公司的试剂超过12个月证明了试剂的可靠性,并可进行成本比较。

缩写

DRI = 诊断试剂公司;EMIT = 酶放大免疫分析技术;d.a.u. = 滥用药物;PCP = 苯环利定;GC/MS = 气相色谱/质谱联用

相似文献

1
Evaluation of DRI enzyme immunoassays for drugs-of-abuse screening on the Cobas Mira.在Cobas Mira上对滥用药物筛查的直接读数免疫测定法进行评估。
Clin Lab Sci. 1997 Mar-Apr;10(2):83-6.
2
[Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
Arch Kriminol. 1998 Nov-Dec;202(5-6):165-72.
3
Evaluation of the Abuscreen ONLINE assay for amphetamines on the Hitachi 737: comparison with EMIT and GC/MS methods.在日立737上对用于检测苯丙胺类药物的Abuscreen ONLINE检测法的评估:与EMIT和气相色谱/质谱联用方法的比较。
J Forensic Sci. 1995 Jan;40(1):108-12.
4
Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.人体尿液样本中麻黄碱、伪麻黄碱和苯丙醇胺浓度的评估以及药物滥用认定(DRI)安非他明和在线阿布斯creen(KIMS)安非他明筛查免疫分析特异性的比较。
J Forensic Sci. 2004 Jan;49(1):160-4.
5
Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
Forensic Sci Int. 2006 Mar 10;157(2-3):106-16. doi: 10.1016/j.forsciint.2005.03.022.
6
Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.在日立917上使用Abuscreen OnLine分析法对尿液中滥用药物进行筛查时,其与其他免疫化学检测方法以及气相色谱/质谱联用仪(GC/MS)相比的精密度和可比性。
Clin Lab. 2000;46(1-2):49-52.
7
Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood.免疫分析法在尸检血液中阿片类药物、大麻素和苯丙胺筛查中的性能。
Forensic Sci Int. 2003 Jan 28;131(2-3):148-55. doi: 10.1016/s0379-0738(02)00430-9.
8
CEDIA for screening drugs of abuse in urine and the effect of adulterants.
J Forensic Sci. 1995 Jul;40(4):614-8.
9
Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.改良筛查免疫分析法以检测尿液中可卡因、大麻素和阿片类药物的亚阈值浓度:用于检测孕产妇和新生儿的药物暴露情况。
Ann Clin Lab Sci. 2000 Jan;30(1):85-91.
10
Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
J Anal Toxicol. 1995 Mar-Apr;19(2):99-103. doi: 10.1093/jat/19.2.99.

引用本文的文献

1
Validation and quality control of protein microarray-based analytical methods.基于蛋白质微阵列分析方法的验证与质量控制
Mol Biotechnol. 2008 Jan;38(1):19-31. doi: 10.1007/s12033-007-0066-5. Epub 2007 Aug 3.